Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Edmond de Rothschild Investment Partners
Biotech
Grey Wolf bags cash to advance small molecule I-O program
The series A, which was backed by Andera Partners and Canaan, will fund work to render more tumors vulnerable to checkpoint inhibitors.
Nick Paul Taylor
Feb 11, 2019 8:34am
Ionis-backed Dynacure bags €47M to start clinical trials
Jul 6, 2018 4:00am
Crescendo raises $70M to trial bispecific T-cell engager
Apr 30, 2018 8:48am
De Rothschild raises €345M Europe-skewed life science fund
Feb 7, 2018 3:05am
Genoa scores $62M Series A to take IPF drug into the clinic
May 15, 2017 5:12am
MedLumics raises $37M for trials of atrial fibrillation device
Mar 20, 2017 10:37am
